377 related articles for article (PubMed ID: 26138586)
61. A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
Sapre N; Macintyre G; Clarkson M; Naeem H; Cmero M; Kowalczyk A; Anderson PD; Costello AJ; Corcoran NM; Hovens CM
Br J Cancer; 2016 Feb; 114(4):454-62. PubMed ID: 26812572
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
[TBL] [Abstract][Full Text] [Related]
63. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
64. Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
Zhao L; Li J; Xue Z; Wang J
Clin Transl Oncol; 2024 Jun; 26(6):1497-1507. PubMed ID: 38227115
[TBL] [Abstract][Full Text] [Related]
65. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.
Yafi FA; Brimo F; Steinberg J; Aprikian AG; Tanguay S; Kassouf W
Urol Oncol; 2015 Feb; 33(2):66.e25-31. PubMed ID: 25037483
[TBL] [Abstract][Full Text] [Related]
66. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
[TBL] [Abstract][Full Text] [Related]
67. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
[TBL] [Abstract][Full Text] [Related]
68. Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Tölle A; Blobel CC; Jung K
Biomark Med; 2018 Jun; 12(6):667-676. PubMed ID: 29896971
[TBL] [Abstract][Full Text] [Related]
69. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
[TBL] [Abstract][Full Text] [Related]
70. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
[TBL] [Abstract][Full Text] [Related]
71. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
[TBL] [Abstract][Full Text] [Related]
72. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
[TBL] [Abstract][Full Text] [Related]
73. Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.
Eissa S; Safwat M; Matboli M; Zaghloul A; El-Sawalhi M; Shaheen A
Urol Oncol; 2019 Apr; 37(4):292.e19-292.e27. PubMed ID: 30654976
[TBL] [Abstract][Full Text] [Related]
74. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
[TBL] [Abstract][Full Text] [Related]
75. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Droller MJ
J Urol; 1998 Aug; 160(2):619-20. PubMed ID: 9679940
[No Abstract] [Full Text] [Related]
76. Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.
Sin MLY; Mach KE; Sinha R; Wu F; Trivedi DR; Altobelli E; Jensen KC; Sahoo D; Lu Y; Liao JC
Clin Cancer Res; 2017 Jul; 23(14):3700-3710. PubMed ID: 28193625
[No Abstract] [Full Text] [Related]
77. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
78. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Andreu Z; Otta Oshiro R; Redruello A; López-Martín S; Gutiérrez-Vázquez C; Morato E; Marina AI; Olivier Gómez C; Yáñez-Mó M
Eur J Pharm Sci; 2017 Feb; 98():70-79. PubMed ID: 27751843
[TBL] [Abstract][Full Text] [Related]
79. Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer.
Ingelmo-Torres M; Lozano JJ; Izquierdo L; Carrion A; Costa M; Gómez L; Ribal MJ; Alcaraz A; Mengual L
Oncotarget; 2017 Mar; 8(11):18238-18247. PubMed ID: 28212556
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer.
Armstrong DA; Green BB; Seigne JD; Schned AR; Marsit CJ
Mol Cancer; 2015 Nov; 14():194. PubMed ID: 26576778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
